888-416-9305 info@abterrabio.com
NGS During The Hybridoma Generation Process

NGS During The Hybridoma Generation Process

NGS During The Hybridoma Generation Process Next-generation sequencing (NGS) has allowed for unprecedented insights into patterns of the immune response. It can enable high-throughput sequencing of hybridomas as we have discussed in NGS-Enhanced antibody discovery...
De Novo Antibody Sequencing Case Study

De Novo Antibody Sequencing Case Study

De Novo Antibody Sequencing Case Study Abterra Bio uses bioinformatics and mass spectrometry to reconstructs the full amino acid sequence of both antibody chains. We’ve successfully sequenced human, mouse, rat, hamster, rabbit, and llama antibodies. This approach can...
Immune Repertoire Sequencing in Human

Immune Repertoire Sequencing in Human

Immune Repertoire Sequencing in Human Immune repertoire sequencing enables deeper understanding of the adaptive immune response [1].  Abterra Biosciences has developed Reptor™, a flexible immune repertoire sequencing and analysis service. In this study, we analyzed...
Clonal Hit-Expansion Case Study

Clonal Hit-Expansion Case Study

Clonal Hit-Expansion Case Study Abterra Bio uses next-generation sequencing to mine the clonal lineage of serum-identified antibodies. This method rescues relatives of hits that are within a clone and increases diversity in your antibody discovery campaign.  Contact...
Llama Immune Repertoire Profiling

Llama Immune Repertoire Profiling

Llama Immune Repertoire Profiling Alicanto® is Abterra Biosciences’ proprietary antibody discovery platform that mines the entire immune response to identify diverse, functional antibodies. For an overview of the proteogenomic process, read more about Alicanto®....

Subscribe To Our Newsletter!

Don't miss out on the latest case studies, posters, and other news.

You have Successfully Subscribed!